Muscle Relaxants in Anesthesia
Core Recommendation
For routine anesthesia, use intermediate-acting non-depolarizing neuromuscular blockers (rocuronium, atracurium, or cisatracurium) with mandatory quantitative Train-of-Four (TOF) monitoring, and reverse all patients before extubation using either neostigmine (when TOF count = 4) or sugammadex (dose-adjusted to blockade depth) to achieve TOF ratio ≥ 0.9. 1
Non-Depolarizing Neuromuscular Blockers for Routine Use
The 2020 Anaesthesia guidelines identify three primary agents for routine anesthesia 1:
Recommended Agents:
- Rocuronium (steroidal)
- Atracurium (benzylisoquinolinium)
- Cisatracurium (benzylisoquinolinium)
These intermediate-acting agents provide predictable neuromuscular blockade while minimizing the risk of prolonged residual paralysis that plagued older long-acting agents like pancuronium 2.
Monitoring Requirements
Quantitative Monitoring is Mandatory
You must use quantitative TOF monitoring whenever neuromuscular blocking agents are administered 1, 3, 4. This is not optional—subjective clinical assessment and qualitative monitoring are inadequate and dangerous.
- Monitor at the adductor pollicis (hand muscles)
- Target: TOF ratio ≥ 0.9 before extubation
- Visual or tactile assessment alone is insufficient and leads to undetected residual blockade 5, 3
The 2025 Japanese Society of Anesthesiologists guidelines explicitly mandate quantitative monitoring with documented TOF ratio ≥ 0.9 at the hand before tracheal extubation 4. This represents the current standard of care.
Reversal Strategy: Algorithm-Based Approach
Decision Point 1: Assess Blockade Depth
Use quantitative TOF monitoring to determine blockade depth, which dictates your reversal strategy 1.
Neostigmine Reversal Algorithm
Use for atracurium, cisatracurium, or rocuronium 1
Step 1: Evaluate TOF Response
- If TOF count < 4: Wait and maintain anesthesia, reassess later
- If TOF count = 4: Proceed to reversal
Step 2: Administer Neostigmine
- Dose: 0.04 mg/kg (40 mcg/kg)
- With atropine: 0.02 mg/kg (20 mcg/kg)
- Expected time to TOF ratio ≥ 0.9: 10-20 minutes 1
Critical Caveat:
The deeper the blockade at reversal, the longer recovery takes (10-30 minutes) 1. You cannot reverse deep blockade (TOF count < 4) with neostigmine—you must wait for spontaneous recovery first. After neostigmine administration, continue quantitative monitoring to confirm adequate recovery 1.
Sugammadex Reversal Algorithm
Use specifically for rocuronium or vecuronium (steroidal agents only) 1
Dose Based on Blockade Depth:
Very Shallow Blockade (TOF ratio ≥ 0.5):
- Sugammadex 0.22 mg/kg
- Recovery to TOF ratio > 0.9 in < 5 minutes 1
Moderate Blockade (TOF count = 4):
- Sugammadex 1.0 mg/kg
- Recovery in < 5 minutes
- (0.5 mg/kg also effective but slower at 10 minutes) 1
Moderate-Deep Blockade (TOF count = 2):
- Sugammadex 2.0 mg/kg minimum
- Recovery in < 5 minutes 1
Deep Blockade (Post-Tetanic Count 1-2, TOF count = 0):
- Sugammadex 4.0 mg/kg
- Recovery in 3-5 minutes 1
Very Deep/Immediate Reversal:
- Sugammadex 8.0 mg/kg
- Recovery in 3-5 minutes 1
Dosing Considerations:
- Dose based on ideal body weight, not actual weight 1
- Continue quantitative monitoring after sugammadex to detect recurarization 1
Critical Pitfalls to Avoid
1. Inadequate Sugammadex Dosing
Underdosing sugammadex causes recurarization—a dangerous phenomenon where neuromuscular blockade returns after initial recovery 1, 2. This occurs because sugammadex encapsulates rocuronium in a 1:1 molecular ratio; insufficient sugammadex leaves free rocuronium molecules to re-bind acetylcholine receptors 1.
2. Extubation Without Quantitative Confirmation
Never extubate based on clinical signs alone (head lift, grip strength, tidal volume). These tests are insensitive and miss clinically significant residual blockade 5, 3. Despite modern agents and reversal drugs, residual neuromuscular blockade still occurs in approximately 50% of patients when quantitative monitoring is not used 3.
3. Special Populations Requiring Dose Adjustment:
- Elderly patients: Sugammadex efficacy is decreased 1
- Severe renal failure (CrCl < 30 mL/min): Sugammadex efficacy significantly reduced, especially for deep blockade 1
4. Attempting Neostigmine Reversal of Deep Block
Neostigmine cannot reverse deep neuromuscular blockade (TOF count < 4). Attempting this leads to prolonged paralysis and respiratory complications 1. You must either wait for spontaneous recovery or use sugammadex if rocuronium was used.
Why This Matters: Patient Safety
Residual neuromuscular blockade causes:
- Hypoxia
- Atelectasis
- Aspiration pneumonia
- Upper airway obstruction
- Critical respiratory events in the post-anesthesia care unit 5, 3, 4
The TOF ratio at hand muscles indicates recovery of upper airway muscles, which are highly sensitive to neuromuscular blocking agents. Achieving TOF ratio ≥ 0.9 ensures both adequate ventilatory recovery and safe airway protection 4.
Practical Implementation
- Administer intermediate-acting NMBA (rocuronium, atracurium, or cisatracurium)
- Apply quantitative TOF monitoring at adductor pollicis from induction through emergence
- Before extubation: Assess blockade depth quantitatively
- Reverse based on algorithm:
- Neostigmine 0.04 mg/kg (with atropine) if TOF count = 4
- Sugammadex (dose per blockade depth) for rocuronium/vecuronium at any depth
- Confirm TOF ratio ≥ 0.9 before extubation
- Continue monitoring post-reversal to detect recurarization
This systematic approach, mandated by current European and Japanese guidelines 1, 3, 4, eliminates the preventable morbidity associated with residual neuromuscular blockade.